(Q40579834)

21 September 2017

IL-6 regulates CD44 cell surface expression on human myeloma cells (English)

1 reference

21 September 2017

Vincent T

1

1 reference

PubMed ID

15014527

21 September 2017

Mechti N

series ordinal

2

1 reference

21 September 2017

1 May 2004

1 reference

21 September 2017

1 reference

21 September 2017

18

1 reference

21 September 2017

5

1 reference

21 September 2017

967-975

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403333

21 September 2017

0 references

cites work

The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Hyaluronic acid induces survival and proliferation of human myeloma cells through an interleukin-6-mediated pathway involving the phosphorylation of retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

In vitro culture of primary plasmacytomas requires stromal cell feeder layers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Forms and functions of CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

CD44 is the principal cell surface receptor for hyaluronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Characterization of hyaluronan synthase expression and hyaluronan synthesis in bone marrow mesenchymal progenitor cells: predominant expression of HAS1 mRNA and up-regulated hyaluronan synthesis in bone marrow cells derived from multiple myeloma pat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Heparan sulfate: decoding a dynamic multifunctional cell regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Hyaluronan, a major non‐protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Transcriptional and post-transcriptional regulation of c-myc expression during the differentiation of murine erythroleukemia Friend cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Expression of CD44 isoforms in neuroblastoma cells is regulated by PI 3-kinase and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Plasma cells for a lifetime?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

CD44 is required for two consecutive steps in HGF/c-Met signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Phenotypical alterations induced by glucocorticoids resistance in RPMI 8226 human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

CD44: a new means to inhibit acute myeloid leukemia cell proliferation via p27Kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Prevention of tumor metastasis formation by anti-variant CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

Heparan Sulfate-modified CD44 Promotes Hepatocyte Growth Factor/Scatter Factor-induced Signal Transduction through the Receptor Tyrosine Kinase c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

7 January 2021

Interleukin-6 inhibits apoptosis of malignant plasma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

7 January 2021

CD130 rather than CD126 expression is associated with disease activity in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

7 January 2021

Integrin-mediated drug resistance in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

7 January 2021

CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

7 January 2021

CD44 variant isoforms are involved in plasma cell adhesion to bone marrow stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

7 January 2021

CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

7 January 2021

TNF-alpha induction of CD44-mediated leukocyte adhesion by sulfation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

7 January 2021

TNFalpha and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

7 January 2021

Selective and differential binding of interleukin (IL)-1 alpha, IL-1 beta, IL-2 and IL-6 to glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

7 January 2021

Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403333

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403333

1 reference

PubMed ID

15014527

Dimensions Publication ID

21 September 2017

0 references

1 reference

PubMed ID

15014527